| Gene Therapy Net Newsletter |
|
|
| |
| |
News: Gene Therapy Turns to the Use of Synthetic Biology Principles
|
|
|
|
|
A new university spinout company is hoping to use synthetic biology to transform gene therapy manufacture. SynGenSys, from the University of Sheffield, plans to tap into engineering design principles to create synthetic promoters to target therapeutic genes to the correct patient tissues. “Typically, people use viral promoters, such as cytomegalovirus as their go-to promoter, but it’s a really complex piece of DNA active in many human tissues,” says David C. James, PhD, professor of bioprocess engineering and co-founder of SynGenSys.
Read more…
|
|
|
|
|
|
|
|
Conference: 4th Neuroimmunology Drug Development Summit
|
|
|
|
|
Since 2019, venture capitalists have been predicting a “golden era of neuroscience products” and successes of “radical new breakthrough therapies” in the notoriously challenging space.
Now, three years on, 2022 is hosting the neuroscience renaissance and pharma is doubling down to understand the neuropathological and neuroprotective role of neuroinflammation as the most promising opportunity to bring more targeted, precise and transformative therapies to neurodegenerative and neuropsychiatric diseases.
The 4th Neuroimmunology Drug Development Summit, April 18-20, 2022, is the timely, industry-definitive forum providing actionable insights to target neuroimmunological mechanisms and advance drug development addressing neuroinflammation.
Register now…
|
|
|
|
|
|
|
|
Conference: Global Bioprocessing Summit 2022
|
|
|
|
|
Conferenzia World’s Global Bioprocessing Summit 2022 has returned with its 6th Edition in a physical setting on April 21-22, 2002 in Berlin, Germany. Industry, together with professionals and scientists are making their way to Berlin for Global Bioprocessing Summit 2022 in April next year to share day-to-day challenges and discuss practical solutions for the development, manufacture, and quality of antibodies, vaccines, and gene therapies. Are you looking for novel tools and technologies for intensive and reliable bioprocessing or improved efficacy, safety, and characterization of cell and gene therapies? How to address the challenges associated with the production and manufacturing of cell and gene therapies? What are the regulatory and automation hurdles? etc. Then, don't miss out on this opportunity to learn from our experts.
Register now…
|
|
|
|
|
|
|
|
Conference: SMi’s 9th Annual Conference Pre-Filled Syringes East Coast
|
|
|
|
|
The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference, April 25-26, 2002, will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.
The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. As part of SMi’s leading injectable series, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design, advances in parenteral device platforms and development, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems.
Register now…
|
|
|
|
|
|
|
|
Conference: 3rd Supply Chain and Logistics for Cell Therapies Summit
|
|
|
|
|
Keen to unite with your celltherapy supply chain community and gain actionable insights for streamlining logistics, implementing digital platforms and optimizing patient operations to establish a reliable global delivery of cell therapies? Then look no further! The 3rd Supply Chain & Logistics for Cell Therapies Summit is back and taking place in-person for the first time this April 25-27, 2022!
Save 10% with your exclusive discount code. Use MP10 at checkout to save up to $1,650 on your ticket.
Register now…
|
|
|
|
|
|
|
|
Conference: 5th Neoantigen Summit Europe
|
|
|
|
|
The 5th Neoantigen Summit Europe, April 26-28, 2022, the definitive industry meeting for uncovering the full potential of neoantigens in creating individualised neoantigen vaccines is returning in person!
From understanding the latest clinical insights to reviewing vaccines post-COVID, our 35+ expert speakers and 3-day agenda developed alongside Vaccibody, Gritstonebio, Targovax, Vaximm, Immunetune and OdimmaTherapeutics will help you advance your pipeline to successfully weaponise neoantigens for anti-tumour treatment. Join 100+ colleagues and take on the next frontier in neoantigen identification and vaccine manufacturing. Discount code: MP10 for 10% off.
Register now…
|
|
|
|
|
|
|
|
Conference: 2nd Annual Gene Therapy R&D Analytics
|
|
|
|
|
A vast number of mainstream and emerging biotechs are now engaged in the discovery and development of gene therapies, but significant advances in analytical and process technologies are required to support preclinical and clinical development, quality control strategies and progression through the regulatory steps needed to reach the market. CHI’s Gene Therapy R&D Analytics conference offers an opportunity for leading scientists to share their experiences with new methods and technologies – and what works and doesn’t work – to move efficiently in this explosive new field of pharmaceutical science. Learn more and reserve your spot at www.PEGSummit.com/gene-therapy-conference, May 5 - 6, 2022. Use discount Code GTN10 for a 10% off the published conference rate.
Register now…
|
|
|
|
|
|
|
|
Conference: 4th Allogeneic Cell Therapies Summit
|
|
|
|
|
Capitalize on the “holy grail” cell therapy approach at the 4th Allogeneic Cell Therapies Summit, May 9-12, 2022, the leading industry-focused meeting to capture cutting-edge advances across pre-clinical development, translation, manufacturing, supply and storage, to accelerate the successful clinical translation of your allogeneic pipeline.
Join this fast-evolving community to compare and contrast platform technology to improve durability and persistence, review the strategy for selecting gold-standard donor starting material, and learn about the latest developments in gene engineering and serve as the “off-the-shelf” ready-to-use therapeutic agents for large-scale clinical applications.
Register now…
|
|
|
|
|
|
|
|
Conference: 4th Annual Conference Injectable Drug Delivery
|
|
|
|
|
There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027.
This year’s event will highlight innovations within the industry with regard to injectable device design and the formulation challenges of long-lasting, highly viscous and high volume drug delivery. There will be an additional focus on the impact that covid has had on advances within this industry over the past year. The 4th Annual Conference Injectable Drug Delivery conference, May 11-12, 2022, will also highlight the significance of sustainability within the injectable drug delivery industry, whilst providing regulatory insight on the changes that have occurred.
Register now…
|
|
|
|
|
|
|
|
Conference: Advanced Therapies - Challenges for Routine Applications
|
|
|
|
|
In recent years, Advanced Therapy Medicinal Products (ATMP) have evolved into a promising and highly hoped-for medical approach to cure a broad spectrum of inherited and acquired human diseases, ranging from cancer to immunological disorders and rare diseases. However, the path from development to clinical application is not yet routine.
At the Advanced Therapies conference, May 17-18, 2022 in Frankfurt, an exciting programme with renowned keynote speakers will highlight the challenging field of gene and cell therapeutics. Advances in iPSC- and MSC-derived therapeutics, therapeutic exosomes and tumor vaccines will be presented. Different innovative manufacturing strategies – scalable, automated, modular, personalized, and clinic-based – will be discussed as well as clinical applications and the regulatory framework. The focus of the conference is on the path to safe and beneficial advanced therapies for the patient.
Register now…
|
|
|
|
|
|
|
|
Conference: Next Generation RNA Therapeutics Summit
|
|
|
|
|
Are you looking to solve challenges with current RNA therapeutics, such as the degradation of RNA by RNAses, the difficulty of RNA crossing the cell membrane by diffusion and the immunogenicity elicited by exogenous RNA?
Next generation RNA therapeutics can help! The Next Generation RNA Therapeutics Summit comes to Boston on May 24-26, 2022, to unite experts to discuss how novel modalities from self-replicating to circular RNAs have the potential to overcome key challenges faced by current generations.
Don’t miss your chance to hear from speakers from Pfizer, Moderna, Kernal Biologics, Replicate Bioscience, Orna Therapeutics, BioNTech and more at the only summit dedicated to successfully translating safe and effective next generation RNA therapeutics into the clinic.
Gene Therapy Net is also pleased to announce our exclusive discount code for your use. Save 10% on your pass to the summit with the code GTN10!
Register now…
|
|
|
|
|
|
|
|
Upcoming conferences and meetings
|
|
|
|
- 22 - 24 March 2022 - Bioprocessing Summit Europe - Barcelona, Spain
- 28 - 30 March 2022 - 10th Neurodegenerative Drug Development Summit - Boston, MA
- 28 - 30 March 2022 - Advancing Gene Therapy 2022 - Boston, MA
- 29 - 31 March 2022 - 3rd Gene Therapy for Blood Disorders Summit - Boston, MA
- 29 March - 1 April 2022 - 2nd Gene Therapy Comparability Summit - Boston, MA
- 30 March - 1 April 2022 - Innate Killer Summit - San Diego, CA
- 6 – 8 April 2022 - Global Bioprocessing Summits - Cell & Gene therapy analytics - San Francisco, CA
- 4 – 7 April 2022 - 2nd Gene Therapy for Muscular Disorders Summit - Boston, MA
- 13 – 15 April 2022 - European Society of Gene and Cell Therapy (ESGCT) Spring School - Athens, Greece
- 18 – 20 April 2022 - 4th Neuroimmunology Drug Development Summit - Boston, MA
- 19 – 21 April 2022, 2nd Gene Therapy Medical Affairs Summit, Boston, MA
- 21 - 22 April 2022 - Global Bioprocessing Summit - ATMP Development - Berlin, Germany
- 25 - 26 April 2022 - 9th Annual Conference Pre-Filled Syringes East Coast - Viral vector deliveries - Boston, MA
- 25 - 27 April 2022 - 3rd Supply Chain and Logistics for Cell Therapies Summit, Boston, MA
- 26 - 28 April 2022 - 5th Neoantigen Summit Europe - T-cell therapies - Amsterdam, the Netherlands
- 2 – 6 May 2022 - PEGS Boston Summit - Gene Therapy R&D Analytics - Boston, MA
- 9 – 12 May 2022 - 4th Allogeneic Cell Therapies Summit - Boston, MA
- 11 - 12 May 2022 - SMi’s 4th Annual Conference Injectable Drug Delivery - Gene Therapies - London, UK
- 11 – 13 May 2022 - Global Bioprocessing Summit Europe - Cell & Gene therapy analytics - Frankfurt, Germany
- 16 - 19 May 2022 - American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting - Washington, D.C.
- 17 - 18 May 2022 - Advanced Therapies (ATMP) – Challenges for Routine Applications - Frankfurt am Main, Germany
- 24 - 26 May 2022 - 2nd Genetic Vaccine Development for Infectious Diseases Summit - Boston, MA
- 24 - 26 May 2022 - ALS Drug Development Summit - Gene & Cell Therapies - Boston, MA
- 24 - 26 May 2022 - Next Generation RNA Therapeutics Summit - Boston, MA
- 30 May - 1 June 2022 - 3rd Annual Gene Therapy Analytical Development Europe Summit 2022 - London, UK
- 7 - 9 June 2022 - 2nd Annual Gene Therapy Patient Engagement Summit - Boston, MA
- 13 - 17 June 2022 - 9th Monolith Summer Symposium, mRNA, Vaccines, Gene Therapy Vectors - Portoroz, Slovenia
- 14 - 16 June 2022 - Next Generation CAR & T Cell Therapies 2022 event - San Francisco, CA
- 20 - 23 June 2022 - 2nd Inner Ear Disorders Therapeutics Summit - Gene Therapies - Boston, MA
- 29 - 30 June 2022 - Onco Cell Therapy Summit (OCTS) - Boston, MA
- 12 - 14 July 2022 - In Vivo Engineering of Therapeutic Cells Summit - Boston, MA
- 18 - 20 July 2022 - 2nd Annual Next Generation Gene Therapy Vectors Summit - Boston, MA
- 26 - 28 July 2022 - 2nd Annual mRNA-Based Therapeutics Summit - Boston, MA
- 26 - 28 September 2022 - International Human Gene Therapy Conference - Melbourne, Australia
- 11 – 14 October 2022 - XXIX Congress of the European Society of Gene and Cell Therapy (ESGCT) - Edinburgh, UK
|
|
|
|
|
|
|
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
